![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 26, 23653-23660, June 29, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, October 30, 2000, and in revised form, April 20, 2001
The small nuclear
C3HC4 finger protein (SNURF), RNF4, acts
as transcriptional coactivator for both steroid-dependent
and -independent promoters such as those driven by androgen response
elements and GC boxes, respectively. However, SNURF does not possess
intrinsic transcription activation function, and the precise molecular
mechanism of its action is unknown. We have studied herein the
interaction of SNURF with DNA in vitro. SNURF binds to
linear double-stranded DNA with no apparent sequence specificity in a
cooperative fashion that is highly dependent on the length of the DNA
fragment used. SNURF interacts efficiently with both supercoiled
circular and four-way junction DNA, and importantly, it also recognizes
nucleosomes. An intact RING structure of SNURF is not mandatory for DNA
binding, whereas mutations of specific positively charged residues in
the N terminus (amino acids 8-11) abolish DNA binding. Interestingly, the ability of SNURF to interact with DNA is associated with its capability to enhance transcription from promoters containing GC box
elements. Because SNURF can interact with both DNA and protein
(transcription) factors, it may promote assembly of nucleoprotein structures.
RING1 (really
interesting new gene) finger is a motif of conserved cysteines and
histidines that coordinate two zinc atoms in a "cross-brace"
system, a ligation scheme distinct from those of the classical zinc
fingers (1, 2). The RING motifs can be classified into two subgroups
according to the presence of a cysteine or histidine in the fifth
position: C3HC4 (RING-HC) and
C3H2C3 (RING-H2) fingers. Otherwise
their composition and length can vary substantially. The RING finger
has been found in a variety of eukaryotic proteins of diverse
evolutionary origin that are involved in various cellular processes
such as oncogenesis, development, signal transduction, and apoptosis
(1-3). RING fingers have been shown to mediate protein-protein
interactions and formation of multi-protein complexes. The RING motif
of promyelocytic leukemia gene product is important in the
assembly of protein complexes linked to SUMO-1 (a small ubiquitin-like
modifier protein) modifications (4). RING finger has also been
suggested to act as a DNA-binding motif (5). The function of many
RING-containing proteins can be mediated through DNA binding or
chromatin association. RAG1 is involved in V(D)J recombination complex,
and RAD-16 participates in DNA repair (6). RING finger-containing
polycomb group proteins Psc, Su(z)2, Bmi-1, and RING1 are
involved in the maintenance of the transcriptionally repressed state of
genes by regulating chromatin structure (7-9), and Mel-18 is shown to
act as a transcriptional repressor via binding to specific
DNA sequence (10). Nuclear receptor mediator TIF Recent intriguing results have shown that many RING proteins are able
to mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination in vitro (13, 14) and thus act as E3
ubiquitin ligases. However, as pointed out by Lorick et al.
(13), only some of these proteins are likely to function primarily as
E3s, and the RING finger-mediated ubiquitination probably provides many
of these proteins with a self-regulatory function.
The small nuclear RING finger protein SNURF was initially identified as
an androgen receptor (AR)-interacting protein by yeast two-hybrid
screening. Rat SNURF is a highly hydrophilic protein composed of 194 amino acid residues of which about 30% are charged (15). The charge
distribution of SNURF is asymmetrical; two negatively charged regions
separate three basic amino acid clusters. The N terminus of SNURF
encompasses a bipartite nuclear localization signal, and the
C3HC4-type RING motif is localized in the
C-terminal region. SNURF interacts with AR via its
N-terminal region, whereas the RING finger plays a key role in the
binding to promoter specificity protein 1 (Sp1) (16). In addition to AR
and other steroid receptors, SNURF also enhances the activity of
Sp1-regulated transcription. In contrast to many other coactivators,
SNURF does not possess a conventional activation domain(s). To get
better insight into the biological role of SNURF, we have studied the
interaction of SNURF and its mutated forms with DNA. Our results
indicate that SNURF possesses a general DNA binding activity that may
explain some of its characteristics as a transcription-activating protein.
Materials--
The BaculoGold transfection system and pAcG3X
baculovirus transfer vector were purchased from PharMingen. Protease
inhibitors phenylmethylsulfonyl fluoride (PMSF), leupeptin, pepstatin
A, and aprotinin, as well as double-stranded calf thymus DNA cellulose were obtained from Sigma. Glutathione-Sepharose 4B, CM-Sepharose Fast
Flow, single-stranded DNA agarose, Hybond-enhanced chemiluminescence (ECL) nitrocellulose membrane and ECL detection reagents were from
Amersham Pharmacia Biotech. Horseradish peroxidase-conjugated anti-mouse IgG was from Zymed Laboratories Inc.
Protease factor Xa was purchased from Roche Molecular Biochemicals.
Human Sp1 was from Promega. HMG-1 was purified from calf thymus (17)
and histones were from rat thymus (18).
Production and Purification of SNURF--
Recombinant viruses
for wild-type and RING finger-mutated (C136S/C139S) rat SNURF GST
fusion proteins were produced in Spodoptera frugiperda
Sf9 cells by using the BaculoGold transfection system (15).
Sf9 cells were infected with recombinant virus at multiplicity of infection of 1 plaque-forming unit/cell, and cells were grown for three days. GST-SNURF proteins were extracted at 0 °C by
sonication in a buffer containing 50 mM Tris-HCl (pH 7.8),
50 µM ZnCl2, 10% (v/v) glycerol, 0.1% (v/v)
Nonidet P-40, 1% (v/v) Triton X-100, 300 mM NaCl, 2 mM EDTA, 0.5 mM PMSF, 5 µg/ml leupeptin, 5 µg/ml pepstatin A, and 10 µg/ml aprotinin. Extracts were
centrifuged at 25,000 × g for 30 min. Recombinant
proteins were adsorbed to glutathione-Sepharose 4B beads and eluted in
a buffer containing 20 mM reduced glutathione, 100 mM Tris-HCl (pH 8.0), 150 mM NaCl, 15% (v/v)
glycerol, 0.5 mM dithiothreitol (DTT), 50 µM
ZnCl2, and 0.5 mM PMSF. Alternatively, GST was
cleaved off by using Factor Xa (2 µg of protease/mg GST fusion
protein) in 50 mM Tris-HCl (pH 8.0), 100 mM
NaCl, 1 mM CaCl2, and 10% (v/v) glycerol at
4 °C for 2 h. The protease was removed by CM-Sepharose Fast
Flow chromatography in loading buffer containing 20 mM
Tris-HCl (pH 7.0), 50 mM NaCl, and 1 mM DTT,
and SNURF was eluted by using 300 mM NaCl in loading
buffer. Factor Xa-cleaved SNURF was analyzed by N-terminal
sequencing of polypeptides transferred onto PDVF membrane and by mass
spectrometry. Wild-type SNURF and different SNURF mutants C136S/C139S,
DNA-Cellulose Chromatography--
Proteins (5 µg) were
incubated with 20 µl of double-stranded (ds) calf thymus DNA
cellulose (containing 3 µg of DNA) in 500 µl of binding buffer
containing 20 mM Tris-HCl (pH 8.0), 20 mM NaCl,
0.5 mM DTT, and 10% (v/v) glycerol (19). After incubating at 4 °C for 4 h by rotation and washing four times with 1 ml of binding buffer, bound proteins were eluted stepwise with one volume of
0.1, 0.3, 0.6, and 1.0 M NaCl in binding buffer. Eluted
fractions, flow-through, and first wash were analyzed on 15%
polyacrylamide gels under denaturing conditions (SDS-PAGE), and gels
were stained with GelCode Blue Stain Reagent (Pierce) or Coomassie
Brilliant Blue.
Electrophoretic Mobility Shift Assay (EMSA)--
Retardation
reactions according to Sheflin et al. (20) containing 0.2 pmol of negatively supercoiled or linearized pGEM-9Zf( Reconstitution of Mononucleosomes--
An
XbaI/HincII fragment (164 bp, 1.5 pmol) from
pGL3-basic (Promega) was end-labeled with [ SNURF-Histone Interactions in Vitro--
GST-SNURF or GST
adsorbed onto glutathione-Sepharose 4B beads was first washed with
0.2% (v/w) N-lauroylsarcosine (Sarkosyl) in a binding
buffer containing 20 mM Tris-HCl (pH 7.8), 50 mM NaCl, 0.05% (v/v) Nonidet P-40, 50 µM
ZnCl2, 0.1 mM DTT, 0.2 mM EDTA (pH
8.0), 0.5 mM PMSF, 5 µg/ml pepstatin A, and 10 µg/ml aprotinin and then with binding buffer without Sarkosyl. Sepharose beads containing 20 µg GST or GST-SNURF were incubated alone or with
histones extracted from rat thymus in 500 µl of binding buffer for
4 h at 4 °C and subsequently washed four times with 1 ml of binding buffer containing 400 mM NaCl. Bound histones were
eluted by 0.2% (v/w) Sarkosyl containing binding buffer, samples were analyzed on 15% polyacrylamide gels under denaturing conditions, and
the gels were stained with GelCode Blue stain reagent.
Cell Culture and Transfections--
COS-1 cells were obtained
from American Type Culture Collection and were maintained in
Dulbecco's modified Eagle's medium containing 10% fetal bovine serum
and 25 units/ml of streptomycin and penicillin. For transactivation
assays, 5 × 104 cells were seeded on 12-well plates
24 h prior to transfection using the FuGENE reagent (Roche
Molecular Biochemicals). Four hours before the addition of DNA, the
cells received fresh medium with 10% fetal bovine serum. After 18 h, the medium was changed to Dulbecco's modified Eagle's medium
supplied with 2% fetal bovine serum. Luciferase and Expression and Purification of Recombinant SNURF--
Recombinant
GST-SNURF produced in Sf9 cells was adsorbed onto
glutathione-Sepharose and cleaved with Factor Xa to remove the GST
tail. In addition to the full-length SNURF migrating at ~34 kDa on
SDS-PAGE (11), protease digestion produced smaller amounts of shorter
polypeptides of ~26 kDa and ~16 kDa in size (Fig.
1B). N-terminal sequencing and
mass spectrometric analysis indicated that the 34-kDa product
corresponds to the full-length SNURF. The two smaller polypeptides were
identified as secondary cleavage products of SNURF by Factor Xa (26).
Internal cleavages at Arg85 and at
Arg181 produced an N-terminal SNURF fragment containing two
stretches of basic amino acid residues and a C-terminal fragment
encompassing the RING finger motif, respectively (Fig.
2). The proportion of the full-length
SNURF in GST-cleaved preparation was ~60% of the total protein. In
addition to SNURF fragments, the preparation did not contain other
proteins in detectable amounts.
SNURF Binds to DNA--
Double-stranded calf thymus DNA cellulose
was used as an affinity matrix to examine the DNA binding activity of
SNURF. Proteins were incubated with dsDNA cellulose in low salt, and
the adsorbed proteins were eluted using a stepwise gradient of NaCl.
Most of GST-SNURF bound to DNA and was eluted between 0.3 and 0.6 M NaCl (Fig. 1A). The full-length SNURF lacking
the GST tail was eluted at a salt concentration of 0.6-1.0
M NaCl. The N-terminal SNURF fragment (26 kDa) eluted
together with full-length SNURF, whereas the C-terminal fragment
containing the RING finger motif (16 kDa) was present in the
flow-through fraction (Fig. 1B). High mobility group
protein-1 (HMG-1) was used as a representative of DNA-binding proteins
that display little or no specificity for the target DNA sequence (27).
Interestingly, the adherence of HMG-1 to DNA was more sensitive to the
ionic strength than that of SNURF in that most of the HMG-1 eluted from
dsDNA cellulose at a salt concentration of 0.3-0.6 M NaCl
(Fig. 1C). GST did not adhere to DNA under identical
conditions (Fig. 1D). Similar to HMG-1 (28), SNURF also
binds to single-stranded DNA agarose (results not shown).
Because dsDNA cellulose experiments indicated that SNURF binds to DNA,
it was important to assess whether there is nucleotide sequence
specificity in SNURF binding. To this end, a selection and
amplification binding assay, a polymerase chain reaction-based random
oligonucleotide selection technique, was employed (29, 30). SNURF was
incubated with a 60-bp oligonucleotide containing a 20-bp central
region of degenerate nucleotide sequence. However, these experiments
failed to show any apparent sequence preference for binding of SNURF to DNA.
SNURF Binds Efficiently to Various Types of DNA--
SNURF binding
capacity toward supercoiled and linearized plasmid DNA was compared by
using a gel retardation assay. GST-SNURF was incubated with supercoiled
and linear pGEM-9Zf(
To study further the DNA binding characteristics of SNURF, the
interaction of SNURF with 4H DNA was examined and compared with that of
HMG-1 (31, 32). EMSAs on parallel polyacrylamide gels were used to
compare the binding of SNURF and HMG-1 to 4H DNA and linear DNA (a
232-bp restriction fragment). 32P-Labeled DNA fragments
were incubated with increasing concentrations of SNURF or HMG-1. As
shown in Fig. 4A, SNURF bound
to 4H DNA and formed a weak DNA complex already at <10 nM
protein concentration (lane 2). Most of the probe was
up-shifted at ~40 nM SNURF (lane 4), and an
increase in the amount of protein up-shifted the complex further
(lanes 5 and 6). Interestingly, HMG-1 bound to 4H
DNA less efficiently than SNURF, and the complexes of HMG-1 were less stable during electrophoresis than those formed by SNURF. With linear
DNA, progressive retardation of DNA was observed when the amount of
SNURF was increased (Fig. 4B), indicating that, as in the
case of 4H DNA, more than one SNURF molecule can interact with the same
DNA molecule simultaneously. Comparable DNA binding pattern was
obtained with GST-SNURF (results not shown), ruling out that the
retardation pattern was due to SNURF fragments in protein
preparations.
The Cooperativity of SNURF DNA Binding Is Influenced by the Length
of the DNA Fragment--
To study the influence of the length of
target DNA sequence on the SNURF-DNA interaction, the ability of SNURF
to bind to DNA fragments of varying lengths was compared by using
32P-labeled linear DNA probes in EMSA. Fixed amounts of
labeled DNA of 33, 65, and 135 bp in length were incubated with
increasing amounts of SNURF, and DNA-protein complexes were analyzed
with EMSA. When the 33-bp DNA fragment was used, only The N-terminal Basic Amino Acid Cluster of SNURF Is Critical for
DNA Binding--
To elucidate the regions of SNURF mandatory for the
interaction with DNA, EMSAs were performed with mutated SNURF proteins expressed in Epicurian coli and purified
as GST fusion proteins. GST-SNURF(C136S/C139S), in which two of the
N-terminal cysteines of the RING finger (Fig. 2) were converted to
serines, interacted with the 32P-labeled 232-bp DNA
fragment as efficiently as wild-type GST-SNURF (Fig.
6), indicating that an intact
zinc-coordinated RING structure is not mandatory for the interaction of
SNURF with DNA. The deletion mutant lacking the second basic amino acid
cluster (SNURF
To assess the role of this latter basic amino acid-containing stretch
in DNA binding, arginines and lysines in the region were individually
or together converted to alanines, and the corresponding GST fusion
proteins were analyzed by EMSA. As shown in Fig. 6, mutation of neither
Lys9, Arg10, nor Arg11 alone
reduced significantly the DNA complex formation (lanes 10-12), whereas conversion of Arg8 to Ala resulted in
clearly more labile DNA complexes. When Arg8,
Lys9, Arg10, and Arg11 were all
changed to alanines, the compound mutant (R8-11A/ K9A) bound to DNA as
poorly as the deletion mutant SNURF SNURF Binds to Nucleosomes--
To examine whether SNURF can also
interact with nucleosomes, EMSAs were performed with increasing
amounts of GST-SNURF or SNURF
To determine whether the binding of SNURF to nucleosomes resulted
merely from interaction of this protein with nucleosomal DNA, the
ability of SNURF to bind to free histones was also examined. GST-SNURF
adsorbed onto glutathione-Sepharose beads was incubated with a mixture
of rat thymus histones, and the matrix was then washed extensively with
buffer containing either 0.15 or 0.4 M NaCl and eluted with
Sarkosyl. SDS-PAGE analysis of the proteins bound to the GST-SNURF
matrix revealed that under high salt conditions, only histones H3 and
H4 were specifically retained by SNURF, whereas under a physiological
salt concentration SNURF was capable of interacting with all core
histones as well as histone H1 (Fig. 7B, lane 2,
and data not shown). Collectively, these results suggest that the
binding of SNURF to nucleosomes does not rely only on the ability of
SNURF to interact with DNA.
The Ability of SNURF to Stimulate Transcription Correlates with Its
DNA Binding Activity--
We have previously shown that ectopic
expression of SNURF activates minimal promoters containing Sp1-binding
sites in front of a TATA box (15, 16). SNURF and Sp1 are also able to
cooperate on natural promoters containing GC box elements, such as the
rat p75 neurotrophin receptor promoter corresponding to the same 232-bp fragment as that used as the target DNA sequence in the preceding EMSA
experiments3. To
assess further the importance of the N-terminal basic amino acids of
SNURF in transcriptional activation, COS-1 cells were transfected with
Sp12-TATA-driven luciferase (LUC) reporter (15) along with
wild-type or mutated SNURF expression plasmids. In accordance with our
previous results, the N-terminally truncated SNURF
Because the amino acid cluster critical for DNA binding overlaps with
the potential bipartite nuclear localization signal in SNURF, we also
investigated the subcellular localization of N-terminally mutated SNURF
forms by immunocytochemical analysis in COS-1 cells. As shown in Fig.
8B, D and E, the subcellular localization of neither SNURFR8A nor SNURFR8-11A/K9A differed from
that of the wild-type protein. Although the deletion of the first 20 amino acids of SNURF (the SNURF
To examine whether SNURF and Sp1 can bind at the same time to the
232-bp rat p75 neurotrophin receptor promoter fragment, the
32P-labeled DNA was incubated with purified Sp1 alone or
together with increasing concentrations of GST-SNURF, and the
DNA-protein complexes were separated by EMSA. In the absence of SNURF,
Sp1 formed one major and one minor complex with the probe (Fig.
9, lane 1). When a
concentration of SNURF that alone bound the probe only weakly
(lane 5) was included with Sp1, a third supershifted DNA
complex became visible (Fig. 9, lane 2). When higher
concentrations of SNURF were used with Sp1, most of the probe was
gradually retarded to the position of the latter supershifted
DNA-protein complex (Fig. 9, lanes 3 and 4), and
the phenomenon was dependent on an intact N terminus of SNURF (Fig. 9,
lanes 8-10). In accordance with the restricted ability of
SNURF to interact with short DNA fragments, SNURF did not promote
Sp1-DNA interaction when the GC box was embedded in a short
oligomer2. In sum, these results demonstrate that SNURF and
Sp1 may interact concomitantly with the same target DNA sequence,
although there was no clear cooperative effect by SNURF on the DNA
binding of Sp1 under these in vitro conditions. Promotion of
Sp1-GC box interaction cannot, however, be ruled out as a possible
explanation for the stimulatory action of SNURF on
Sp1-dependent transcription in intact cells.
The rat RING finger protein SNURF was originally isolated as an
androgen receptor-interacting protein in a yeast two-hybrid screen
(15). The corresponding protein in human and mouse has been termed RNF4
(33, 34). These sequences are highly conserved, exhibiting 96%
identity between rat and mouse protein and 91% identity between rat
and human. Interestingly, no obvious SNURF/RNF4 orthologs are found in
Drosophila melanogaster, Caenorhabditis elegans, or Saccharomyces cerevisiae. In addition to
interacting with steroid receptors and Sp1 (15, 16), RNF4 has been
recently shown to associate with Gscl (goosecoid-like) homeodomain
transcription factor (34), the activator of stromelysin I gene
transcription (SPBP) (35), and a novel member of the BTB/POZ family
PATZ (36). Interaction between SNURF and Sp1 or SPBP is mediated
through the RING finger (15, 16, 35), whereas AR and Gscl are
interacting with a region N-terminal to the RING finger (15, 16,
34).
SNURF is able to act as a transcriptional coactivator for different
transcription factors (15, 16, 35), and conversely, to enhance
transcriptional repression elicited by PATZ (36). The actual molecular
mechanism of transcriptional regulation by SNURF is not known as no
clear-cut intrinsic transcription activation or repression function has
been found for SNURF. One potential explanation for the effects of
SNURF is that it associates with DNA. Our results indicate that SNURF
indeed possesses a general DNA binding ability without an apparent
nucleotide sequence specificity. Interaction of SNURF with dsDNA was
found to be more resistant to ionic strength than that of another
non-sequence-specific DNA-binding protein, HMG-1. SNURF was also able
to bind to single-stranded DNA. A similar behavior has been previously
reported for HMG-1 and HMG-2 as well as for HMG-14 and HMG-17 (37).
These HMG proteins are thought to function as architectural proteins
that modify the structure of chromatin to generate conformations that
facilitate or enhance various other DNA-dependent
activities (27). Some non-sequence-specific DNA-binding proteins, such
as Ku autoantigen, recognize preferentially DNA termini (38), which was
a property, however, not inherent to SNURF. With linear DNA molecules,
the cooperative DNA binding mode of SNURF correlated with the length of
the DNA fragment in a fashion that resembles the binding
characteristics of heterochromatin protein 1 (39). Heterochromatin
protein 1, HMG-14, and -17, SNURF also is capable of binding to
nucleosomes (27, 37, 39). In this regard, it is interesting that SNURF can recognize four-way junction DNA and that it shows binding preference for core histones H3 and H4. Binding to these DNA structures is a common property of many architectural proteins, and a wide variety
of structurally and functionally unrelated DNA-binding proteins have
been shown to bind preferentially to four-way junction DNA (40).
Intriguingly, HMGI(Y), that favors binding to the four-way
junctions, has been reported recently to associate with SNURF/RNF4
(36).
Besides the RING structure and the two nuclear localization signals (a
bipartite-type and an SV40-type), no other protein motifs have been
identified in SNURF sequence (Fig. 2). Our results show that the intact
RING finger motif is not essential for the ability of SNURF to bind to
DNA, further supporting the role of this structure as a protein-binding
motif (16). Mutational analyses of the basic amino acid cluster
(8RKRR11), present in the N terminus of
SNURF and overlapping with the bipartite nuclear localization
signal, revealed that this sequence is primarily responsible for
the interaction with DNA and binding to nucleosomes. Of the individual
residues, Arg8 plays a key role in DNA binding. These
results suggest that the SNURF-DNA interaction is mainly electrostatic
in nature. Interestingly, this type of Arg-rich cluster in the
Drosophila homeodomain protein Bicoid is necessary for the
recognition of both DNA and RNA targets (41), and similar motifs are
found in a class of RNA-binding proteins (42). It is, therefore, an
intriguing possibility that, like the Bicoid, SNURF is capable of
recognizing RNA targets as well.
In addition to abolishing the DNA binding of SNURF, mutagenesis of the
N-terminal basic amino acids also blunts the ability of the protein to
stimulate transcription even though this particular SNURF domain is not
centrally involved in heterologous protein interactions (15, 16). The
relative DNA binding activity of various SNURF mutants correlated well
with their ability to enhance transcription, strongly suggesting that
interaction with DNA is essential for SNURF coactivator function. It is
also worth pointing out that the mutations in the N terminus of
SNURF did not alter nuclear localization of the proteins. Because also
the RING finger-disrupted SNURF(C136S/C139S) interacts with DNA but is
incapable of activating Sp1-mediated transcription (16), the binding to
DNA cannot be the sole mechanism governing the ability of SNURF to
activate transcription.
Taken together with our previous results, these data imply that SNURF
enhances Sp1 activity through a combinatorial effect, involving
protein-protein interaction and DNA binding (15, 16). SNURF may
function through a similar mechanism also with other transcription
factors such as Gscl (35). These results are reminiscent of the ability
of HMG-1 to stimulate many sequence-specific transcription factors
including steroid receptors (27, 43). Interestingly, a
non-sequence-specific DNA binding activity has been recently shown for
many coregulatory proteins implicated in steroid receptor function such
as Hap46, TLS/FUS, and C1D/SUN-CoR (44-48). However, we have been
unable to detect an unequivocal augmentation of AR DNA binding
domain-DNA interaction by SNURF in vitro2. This
may reflect the requirement of AR regions outside the DNA binding
domain for an efficient interaction with SNURF (15). With regard to AR,
our additional experiments have shown that SNURF influences nuclear
compartmentalization of the receptor (25). The role of DNA binding
activity of SNURF in this process remains to be elucidated.
In conclusion, our data suggest that SNURF is a bifunctional protein
that can interact both with transcription factors and with
DNA/nucleosomes, thereby promoting the assembly of nucleoprotein structures involved in transcriptional control. A similar bifunctional activity may be a feature common to many transcriptional coregulatory proteins.
We thank Marc Baumann for peptide sequencing
and mass spectrometric analysis, Hetti Poukka for plasmids, Örjan
Wrange for help with nucleosomes, and Kati Saastamoinen and Seija
Mäki for technical assistance.
*
This work was supported by grants from the Medical Research
Council (Academy of Finland), the Finnish Foundation for Cancer Research, the Sigrid Jusélius Foundation, Biocentrum Helsinki, the Helsinki University Central Hospital, and the Association for the Cure of Cancer of Prostate (CaP Cure).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, April 23, 2001, DOI 10.1074/jbc.M009891200
2
M. Häkli, O. A. Jänne, and J. J.
Palvimo, unpublished observations.
3
H. Poukka, O. A. Jänne, and J. J. Palvimo, unpublished observations.
The abbreviations used are:
RING, really
interesting new gene;
SNURF, small nuclear RING finger protein;
AR, androgen receptor;
Sp1, promoter specificity protein 1;
PMSF, phenylmethylsulfonyl fluoride;
GST, glutathione
S-transferase;
DTT, dithiothreitol;
ds, double-stranded;
PAGE, polyacrylamide gel electrophoresis;
EMSA, electrophoretic
mobility shift assay;
4H DNA, four-way junction DNA;
bp, base pair(s);
HMG, high mobility group;
LUC, luciferase.
The RING Finger Protein SNURF Is a Bifunctional Protein
Possessing DNA Binding Activity*
,
,
§, and
¶
Biomedicum Helsinki, Institute of
Biomedicine (Physiology), ¶ Institute of Biotechnology, and the
§ Department of Clinical Chemistry, University of Helsinki,
FIN-00014 Helsinki, Finland
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
is tightly
associated with euchromatin (11), whereas BRCA1 appears to be
associated with the RNA polymerase II holoenzyme (12). However, the
RING structures of these latter proteins have not been implicated in
mediating their binding to chromatin or DNA.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1-20,
66-98,
178-194, K8A, R9A, R10A, R11A, and R8-11A/K9A
were also produced as GST fusion proteins using pGEX-5X-1 vector
(Amersham Pharmacia Biotech) and Epicurian coli BL21 CodonPlus (DE3)-RIL cells (Stratagene). SNURF
C136S/C139S,
1-20,
66-98, and
178-194 GST fusion proteins
were constructed with the aid of polymerase chain reaction and the
corresponding pcDNA3.1(+)-FLAG constructs (16). The GST fusions of
SNURF mutants R8-11A/K9A, R8A, K9A, R10A, and R11A were made by using
oligonucleotide duplexes flanked by BamHI and
EcoRI sites and cloned directly into pGEX-5X-SNURF plasmid.
The SNURF R18-25A/K22A mutant was constructed by using oligonucleotide
duplexes containing AvaI and EcoRI ends. The
bacteria were grown at 37 °C to A600 nm = 0.7 and induced with 0.3 mM
isopropyl-1-thio-
-D-galactopyranoside. Cultures were
harvested after 3 h at 30 °C and GST fusion proteins were
purified by affinity chromatography on glutathione-Sepharose 4B (15).
pcDNA3.1(+)-FLAG-SNURFR8-11A/K9A and pcDNA3.1(+)-FLAG-SNURFR8A were
assembled by transferring the BamHI/XhoI fragments from
pGEX-5X-1 vectors.
) (Promega)
were incubated with various concentrations of SNURF or HMG-1 for 15 min
at 37 °C in 50 mM Tris-HCl (pH 7.5), 50 mM NaCl, 10 mM MgCl2, 0.5 mM DTT, 0.1 mM EDTA, and 0.3 µg/ml bovine serum albumin in a total
volume of 20 µl. The binding reactions were placed on ice for 30 min
and then incubated for 5 min at 37 °C. Samples of the reactions were
separated on 0.7% (w/v) agarose gels using 1× Tris-phosphate-EDTA as
the running buffer, and the gels were stained with ethidium bromide. In
EMSA reactions with shorter DNA fragments, proteins were preincubated
with carrier DNA poly(dI-dC)2 (50 or 100 ng/reaction) on
ice for 10 min in a buffer containing 20 mM Hepes (pH 7.9),
50 mM KCl, 1 mM MgCl2, 10% (v/v)
glycerol, 2 mM DTT, 0.35 mM EDTA, 0.025% (v/v)
Nonidet P-40, 0.25 mM PMSF, 2 µg/ml pepstatin A, 2 µg/ml leupeptin, and 2 µg/ml aprotinin. After the addition of 2 µl of 32P-labeled DNA probe yielding a total volume of 20 µl, samples were incubated at 22 °C for 30 min. Protein-DNA
complexes were resolved on 4% polyacrylamide gel in 0.25× Tris
borate-EDTA at 22 °C. Oligonucleotides
5'-CCCTATACCCCTGCATTGAATTCCAGTCTGATAA-3', 5'-GTAGTCGTGATAGGTGCAGGGGTTATAGG-3',
5'-AACAGTAGCTCTTATTCGAGCTCGCGCCCTATCACGACTA-3', and
5'-TTTATCAGACTGGAATTCAAGCGCGAGCTCGAATAGAGCTACTGT-3' (21) were used to
create a four-way junction DNA (4H DNA) according to Hill et
al. (22) by dissolving appropriate amounts of each oligonucleotide in annealing buffer containing 10 mM
Tris-HCl (pH 7.5), 50 mM NaCl, and 10 mM
MgCl2, heating at 95 °C for 1 min, and cooling slowly to
room temperature. 4H DNA was labeled with [
-32P]ATP
and T4 polynucleotide kinase. 32P-Labeled
HindIII/KpnI fragment (232 bp) of the rat p75
neurotrophin receptor promoter and HindIII/NcoI
(33 bp), BglII/NcoI (65 bp), and
KpnI/NcoI (135 bp) fragments of
Sp12-TATA-LUC were used in additional EMSA experiments
(15, 23).
-32P]dCTP
and Klenow fragment and was mixed with donor chromatin from rat liver
(a gift from Dr. Örjan Wrange, Karolinska Institute,
Stockholm, Sweden) to a final concentration of 0.1 mg/ml in a buffer
containing 1 M NaCl, 15 mM Tris-HCl (pH 7.5), 0.2 mM EDTA, and 0.13 mM PMSF. Nucleosomes were
reconstituted by high salt exchange method and purified by 7 to 30%
glycerol gradient centrifugation (24). Increasing concentrations of
GST-SNURF or the GST-SNURF
1-20 mutant were incubated with a
constant amount of reconstituted nucleosomes, and EMSAs were performed
as described for naked DNA.
-galactosidase
activities and the concentration of soluble cell proteins were assayed
as previously described (15). For immunolocalization of SNURF mutants
in COS-1 cells, cells grown on glass coverslips (1.6 × 105 cells on 6-well plates) were transfected with 750 ng of
pcDNA-FLAG-SNURF or mutated SNURF forms in the same vector (25).
Cells were processed, and immunofluorescence labeling and microscopy
were performed as described in (25).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (29K):
[in a new window]
Fig. 1.
SNURF adheres to DNA cellulose. DNA
binding activity of SNURF was compared with that of HMG-1 by using
double-stranded calf thymus DNA cellulose. GST-SNURF (A),
SNURF lacking the GST tail (B), HMG-1 (C), or GST
alone (D) were incubated with the matrix, washed, and eluted
stepwise with the indicated NaCl concentrations as described under
"Experimental Procedures." Entire eluted fractions, 5% of
flow-through (F) and 5% of washes (W) were
subjected to 15% SDS-PAGE, and the gel was stained with GelCode Blue
stain reagent. Input (I) samples correspond to 20% of the
amount of the proteins incubated with matrices.
![]()
View larger version (13K):
[in a new window]
Fig. 2.
Sequence characteristics of SNURF
protein. The charge distribution of SNURF is asymmetrical;
positively and negatively charged amino acids are indicated by
bolding and underlining, respectively. Cysteine
and histidine residues of C3HC4 type RING
finger motif (boxed) are depicted by asterisks,
and amino acid residues of potential nuclear localization signals are
shown by italics. Arrowheads depict the internal
cleavage sites by Factor Xa.
) DNA (2.9 kb) at various protein:DNA molar
ratios, and protein-DNA interactions were monitored by agarose gel
electrophoresis and ethidium bromide staining. SNURF bound to all the
supercoiled DNA, and the mobility of SNURF-DNA complexes was
progressively retarded with increasing SNURF concentrations (Fig.
3A), a phenomenon typical of
general DNA-binding proteins (20). Similar mobility shift changes are not usually seen with sequence-specific DNA-binding proteins. SNURF
retarded the mobility of both DNA types more efficiently than HMG-1.
However, comparison of the interaction of SNURF between supercoiled and
corresponding linear DNA did not reveal a clear preference for either
DNA type (Fig. 3). GST alone did not interact with DNA.

View larger version (49K):
[in a new window]
Fig. 3.
Binding of SNURF to supercoiled and linear
DNA as analyzed by electrophoretic mobility shift assay. Indicated
molar protein:DNA ratios of GST-SNURF, HMG-1, or GST were incubated
with negatively supercoiled pGEM-9Zf(
)(A) or with the
corresponding linearized DNA (B) as described under
"Experimental Procedures." Protein-DNA complexes were resolved by
electrophoresis on 0.7% agarose gels containing 1×
Tris-phosphate-EDTA and visualized by ethidium bromide staining.

View larger version (53K):
[in a new window]
Fig. 4.
SNURF can interact with four-way junction
DNA. A, increasing concentrations of SNURF (6-140
nM) or HMG-1 (20-550 nM) were preincubated
with 50 ng of poly(dI-dC)2 for 10 min at 0 °C prior to
the addition of 32P-labeled 4H DNA, and the incubation was
continued for 30 min at 22 °C. B, 32P-labeled
linear 232-bp DNA was used instead of 4H DNA under identical
conditions. Protein-DNA complexes were separated on 4% nondenaturing
polyacrylamide gels containing 0.25× Tris borate-EDTA followed by
autoradiography. F
, free DNA.
40% of the
probe was up-shifted at 42 nM SNURF concentration, and the
position of the complexes suggested presence of one or maximally two
SNURF molecules bound to DNA (Fig. 5,
lane 2). In contrast, the 65-bp and 135-bp DNA fragments
were completely shifted at the same protein concentration (Fig. 5,
lanes 6 and 10) and progressive retardation DNA
was observed when 200 nM SNURF was used (Fig. 5,
lanes 7 and 11), indicating that multiple SNURF
molecules can interact with DNA fragments longer than ~60 bp.
However, the SNURF-DNA complexes formed with the 135-bp DNA appeared to
be more stable than those generated with the 65-bp fragment.

View larger version (79K):
[in a new window]
Fig. 5.
DNA binding of SNURF is dependent on the
length of the target DNA fragment. Indicated concentrations of
SNURF were first incubated with 100 ng of poly(dI-dC)2 and
subsequently with 32P-labeled double-stranded DNA of 33 bp
(lanes 1-3), 65 bp (lanes 5-7), or 135 bp
(lanes 9-11) in length as described under "Experimental
Procedures." Protein-DNA complexes were resolved by electrophoresis
on 4% polyacrylamide gels under nondenaturing conditions and
visualized by autoradiography.
66-98) bound to DNA as efficiently as full-length
SNURF, whereas a C-terminal deletion mutant of SNURF (
178-194)
lacking the third basic stretch formed slightly more labile DNA
complexes (Fig. 6). In contrast, the deletion of amino acids 1-20,
including most of the N-terminal basic amino acid cluster, blunted the
ability of SNURF to interact with DNA.

View larger version (81K):
[in a new window]
Fig. 6.
The positively charged amino acids in the N
terminus of SNURF are required for DNA binding. A,
GST-SNURF together with GST fusions of SNURF mutants C136S/C139S,
1-20,
66-98,
178-194, R8-11A/K9A, R8A, K9A, R10A, and R11A
(100 nM each) produced in Epicurian
coli were compared for their ability to bind to
32P-labeled linear 232-bp DNA under conditions described in
Fig. 4. B, SDS-PAGE analysis of the purified GST fusion
proteins used in the EMSA experiment. Proteins (1 µg) were detected
by Coomassie Brilliant Blue staining. F
, free DNA.
1-20. Arginine 18, 23, and 25 as
well as lysine 22 do not appear to play a critical role in DNA binding
because a SNURF mutant having these amino acid residues mutated to
alanines was still capable of binding to
DNA2. Taken together, these
data indicate that amino acids 8-11 are the principal residues
responsible for contacting DNA and that Arg8 plays a
special role in the DNA binding of SNURF.
1-20 and a constant concentration of
nucleosomes that were reconstituted with a 32P-labeled
164-bp DNA fragment. Although the mononucleosome fraction was purified
by glycerol gradient centrifugation, some free DNA was present in the
preparation, which is depicted as the band migrating faster than that
of mononucleosomes (Fig. 7A,
lane 1). This minor contamination of the mononucleosome
fraction with free DNA was, in fact, beneficial as it permitted
comparison of the binding of SNURF to naked DNA and to nucleosomes in
the same assay. As illustrated in Fig. 7, GST-SNURF retarded
efficiently the mobility of the reconstituted nucleosome complex.
However, as shown by the disappearance (upshift) of free DNA at a
somewhat lower SNURF concentration than that of mononucleosomes
(cf. lanes 4 and 6), SNURF appears to bind
slightly more avidly to naked DNA than to nucleosomes. As was the case
with free DNA, the N-terminally truncated SNURF
1-20 was practically
unable to retard nucleosome particles (Fig. 7A, lanes
9-15).

View larger version (47K):
[in a new window]
Fig. 7.
SNURF binds to nucleosomes.
A, 32P-labeled in vitro reconstituted
mononucleosomes were incubated with increasing concentrations
(nM) of GST-SNURF (lanes 2-8), or the
SNURF
1-20 mutant (lanes 9-15). Samples were analyzed on
a 4% nondenaturing polyacrylamide gel at 4 °C and visualized by
autoradiography. Arrow and arrowhead depict the
position of unbound nucleosomes and free DNA, respectively.
B, GST-SNURF or GST immobilized onto glutathione-Sepharose
was incubated with or without rat thymus histones for 4 h at
4 °C, and the matrices were washed extensively with buffer
containing 0.4 M NaCl as described under "Experimental
Procedures." Bound histones were eluted with 0.2% Sarkosyl and
resolved by electrophoresis on 15% SDS-PAGE. Lane 1, 10%
of the input histones; lanes 2 and 4, histones
eluted from GST-SNURF and GST matrices, respectively; and lanes
3 and 5, elutions from GST-SNURF and GST matrices not
incubated with histones, respectively.
1-20 was
practically inactive in this assay, showing
5% of wild-type activity
(Fig. 8A). The extent of DNA
binding of R8-11A/K9A and that of R8A was in line with their ability
to activate Sp12-TATA-LUC reporter in that the latter
mutant with some DNA binding activity displayed ~25% of wild-type
activity in transactivation assays, whereas the behavior of the
compound mutant was comparable with that of SNURF
1-20 in both
analyses. Similar results were obtained with the rat p75 neurotrophin
receptor promoter2. Together these results strongly suggest
that the DNA binding activity of SNURF is essential for the ability of
this protein to activate transcription.

View larger version (54K):
[in a new window]
Fig. 8.
Stimulation of GC box element-driven
transcription is associated with DNA binding ability of the SNURF.
A, COS-1 cells on 12-well plates were transfected using
FuGENE reagent with 160 ng of Sp12-TATA-LUC, 60 ng of
-galactosidase expression vector (pCMV
), and 300 ng of indicated
SNURF expression plasmids in pcDNA3.1(+)-FLAG backbone. After a
40-h culture, the cells were harvested, and luciferase activities in
the cell extracts were adjusted to the transfection efficiency using
-galactosidase as an internal control. The reporter gene activity in
the presence of empty pcDNA3.1(+)-FLAG vector was set as 1. The
mean ± S.E. values of at least six experiments is shown.
Inset, Immunoblot analysis of wild-type and mutant SNURF
proteins in an experiment corresponding to data shown in panel
A. SNURF proteins were immunoblotted from the same lysates (pooled
triplicate dishes) from which reporter gene activities were measured
with an anti-SNURF antibody (15) and using the ECL system. Localization
of wild-type SNURF (B), SNURF
1-20 (C),
SNURFR8-11A/K9A (D), and SNURFR8A (E) in COS-1
cells. Cells grown on glass coverslips on 6-well plates were
transfected with 750 ng of pcDNA-FLAG-SNURF or the corresponding
vector encoding mutant SNURF forms. After a 40-h culture, cells were
fixed with paraformaldehyde (4%) and permeabilized in 0.1% Triton
X-100. SNURF antigen was detected by using anti-FLAG M2 monoclonal
antibody followed by fluorescein isothiocyanate-conjugated secondary
anti-mouse antibody, and immunofluorescence was recorded by using
Bio-Rad MRC-1024 confocal laser system connected to Zeiss Axiovert 135 microscope.
1-20 mutant) resulted in more
cytoplasmic staining than seen with the other SNURF forms, it did not
prevent the truncated protein from entering the nuclei (Fig.
8C). In view of these data, the inability of the DNA
binding-deficient SNURF forms to activate transcription from Sp1
element-containing promoters is not attributed to their altered
subcellular localization.

View larger version (64K):
[in a new window]
Fig. 9.
Concomitant binding of SNURF and Sp1 to the
same DNA target. Purified Sp1 alone (lane 1) or
together with increasing concentrations of GST-SNURF (lanes
2-4) or GST-SNURF
1-20 (lanes 8-10) were
preincubated with 50 ng of poly(dI-dC)2 at 0 °C for 10 min. After the addition of a 32P-labeled 232-bp DNA
fragment corresponding to the proximal promoter of the rat p75
neurotrophin receptor gene, the incubation was continued for 30 min at
22 °C. DNA-protein complexes were separated on a 4% polyacrylamide
gel containing 0.25× Tris borate-EDTA and 0.1% (v/v) Nonidet P-40 and
visualized by autoradiography. F
, free
DNA.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed: Biomedicum
Helsinki, Inst. of Biomedicine (Physiology), Univ. of Helsinki, P. O. Box 63, FIN-00014 Helsinki, Finland. Tel.: 358-9-19125291; Fax:
358-9-19125302; E-mail: jorma.palvimo@helsinki.fi.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Saurin, A. J,
Borden, K. L. B.,
Boddy, M. N.,
and Freemont, P. S.
(1996)
Trends Biochem. Sci.
21,
208-214
2.
Borden, K. L. B.,
and Freemont, P. S.
(1996)
Curr. Opin. Struct. Biol.
6,
395-401
3.
Borden, K. L. B.
(2000)
J. Mol. Biol.
295,
1103-1112
4.
Duprez, E.,
Saurin, A. J.,
Desterro, J. M.,
Lallemand-Breitenbach, V.,
Howe, K.,
Boddy, M. N.,
Solomon, E.,
de The, H.,
Hay, R. T.,
and Freemont, P. S.
(1999)
J. Cell Sci.
112,
381-393
5.
Lovering, R.,
Hanson, I. M.,
Borden, K. L.,
Martin, S.,
O'Reilly, N. J.,
Evan, G. I.,
Rahman, D.,
Pappin, D. J.,
Trowsdale, J.,
and Freemont, P. S.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
2112-2116
6.
Leu, T. M.,
and Schatz, D. G.
(1995)
Mol. Cell. Biol.
15,
5657-5670
7.
Rastelli, L.,
Chan, C. S.,
and Pirrota, V.
(1993)
EMBO J.
12,
1513-1522
8.
Alkema, M. J.,
Bronk, M.,
Verhoeven, E.,
Otte, A.,
van't Veer, L. J.,
Berns, A.,
and van Lohuizen, M.
(1997)
Genes Dev.
11,
226-240
9.
Satijn, D. P. E.,
Gunster, M. J.,
van der Vlag, J.,
Hamer, K. M.,
Schul, W.,
Alkema, M. J.,
Saurin, A. J.,
Freemont, P. S.,
van Driel, R.,
and Otte, A. P.
(1997)
Mol. Cell. Biol.
17,
4105-4113
10.
Kanno, M.,
Hasegawa, M.,
Ishida, A.,
Isono, K.,
and Taniguchi, M.
(1995)
EMBO J.
14,
5672-5678
11.
Remboutsika, E.,
Lutz, Y.,
Gansmuller, A.,
Vonesch, J. L.,
Losson, R.,
and Chambon, P.
(1999)
J. Cell Sci.
112,
1671-1683
12.
Scully, R.,
Anderson, S. F.,
Chao, D. M.,
Wei, W.,
Ye, L.,
Young, R. A.,
Livingston, D. M.,
and Parvin, J. D.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
5605-5610
13.
Lorick, K. L.,
Jensen, J. P.,
Fang, S.,
Ong, A. M.,
Hatakeyama, S.,
and Weissman, A. M.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
10364-10369
14.
Freemont, P. S.
(2000)
Curr. Biol.
10,
R84-87
15.
Moilanen, A-M.,
Poukka, H.,
Karvonen, U.,
Häkli, M.,
Jänne, O. A.,
and Palvimo, J. J.
(1998)
Mol. Cell. Biol.
18,
5128-5139
16.
Poukka, H.,
Aarnisalo, P.,
Santti, H.,
Jänne, O. A.,
and Palvimo, J. J.
(2000)
J. Biol. Chem.
275,
571-579
17.
Goodwin, G. H.,
Rabbani, A.,
Nicolas, R. H.,
and Johns, E. W.
(1977)
FEBS Lett.
80,
413-416
18.
Panyim, S.,
Bilek, D.,
and Chalkley, R.
(1971)
J. Biol. Chem.
246,
4206-4215
19.
Weisshart, K.,
Kuo, A. A.,
Hwang, C. B.,
Kumura, K.,
and Coen, D. M.
(1994)
J. Biol. Chem.
269,
22788-22796
20.
Sheflin, L. G.,
Fucile, N. W.,
and Spaulding, S. W.
(1993)
Biochemistry
32,
3238-3248
21.
Bianchi, M. E.
(1988)
EMBO J.
7,
843-849
22.
Hill, D. A.,
Pedulla, M. L.,
and Reeves, R.
(1999)
Nucleic Acids Res.
27,
2135-2144
23.
Kallio, P. J.,
Poukka, H.,
Moilanen, A.,
Jänne, O. A.,
and Palvimo, J. J.
(1995)
Mol. Endocrinol.
9,
1017-1028
24.
Li, Q.,
and Wrange, Ö.
(1997)
Methods Enzymol.
12,
96-104
25.
Poukka, H.,
Karvonen, U.,
Yoshikawa, N.,
Tanaka, H.,
Palvimo, J. J.,
and Jänne, O. A.
(2000)
J. Cell Sci.
113,
2991-3001
26.
Eaton, D.,
Rodriguez, H.,
and Vehar, A. G.
(1986)
Biochemistry
25,
505-512
27.
Bustin, M.
(1999)
Mol. Cell. Biol.
19,
5237-5246
28.
Butler, A. P.,
Mardian, J. K. W.,
and Olins, D. E.
(1985)
J. Biol. Chem.
260,
10613-10620
29.
Blackwell, T. K.,
Kretzner, L.,
Blackwood, E. M.,
Eisenman, R. N.,
and Weintraub, H.
(1990)
Science
250,
1149-1151
30.
Burden, D. A.,
and Osheroff, N.
(1999)
J. Biol. Chem.
274,
5227-5235
31.
Bianchi, M. E.,
Beltrame, M.,
and Paonessa, G.
(1989)
Science
243,
1056-1059
32.
Duckett, D. R.,
Murchie, A. I.,
Diekmann, S.,
von Kitzing, E.,
Kemper, B.,
and Lilley, D. M.
(1988)
Cell
55,
79-89
33.
Chiariotti, L.,
Benvenuto, G.,
Fedele, M.,
Santoro, M.,
Simeone, A.,
Fusco, A.,
and Bruni, C. B.
(1998)
Genomics
47,
258-265
34.
Galili, N.,
Nayak, S.,
Epstein, J. A.,
and Buck, C. A.
(2000)
Dev. Dyn.
218,
102-111
35.
Lyngsø, C.,
Bouteiller, G.,
Damgaard, C. K.,
Ryom, D.,
Sanchez-Munoz, S.,
Nørby, P. L.,
Bonven, B. J.,
and Jørgensen, P.
(2000)
J. Biol. Chem.
275,
26144-26149
36.
Fedele, M.,
Benvenuto, G.,
Pero, R.,
Majello, B.,
Battista, S.,
Lembo, F.,
Vollono, E.,
Day, P. M.,
Santoro, M.,
Lania, L.,
Bruni, C. B.,
Fusco, A.,
and Chiariotti, L.
(2000)
J. Biol. Chem.
275,
7894-7901
37.
Bustin, M.,
Lehn, D. A.,
and Landsman, D.
(1990)
Biochim. Biophys. Acta
1049,
231-243
38.
Tuteja, R.,
and Tuteja, N.
(2000)
Crit. Rev. Biochem. Mol. Biol.
35,
1-33
39.
Zhao, T.,
Heyduk, T.,
Allis, C. D.,
and Eissenberg, J. C.
(2000)
J. Biol. Chem.
275,
28332-28338
40.
Zlatanova, J.,
and van Holde, K.
(1998)
FASEB J.
12,
421-431
41.
Niessing, D.,
Driever, W.,
Sprenger, F.,
Taubert, H.,
Jäckle, H.,
and Rivera-Pomar, R.
(2000)
Mol. Cell
5,
395-401
42.
Burd, C. G.,
and Dreyfuss, G.
(1994)
Science
265,
615-621
43.
Boonyaratanakornkit, V.,
Melvin, V.,
Prendergast, P.,
Altmann, M.,
Ronfani, L.,
Bianchi, M. E.,
Taraseviciene, L.,
Nordeen, S. K.,
Allegretto, E. A.,
and Edwards, D. P.
(1998)
Mol. Cell. Biol.
18,
4471-4487
44.
Zeiner, M.,
Niyaz, Y.,
and Gehring, U.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
10194-10199
45.
Baechtold, H.,
Kuroda, M.,
Sok, J.,
Ron, D.,
Lopez, B. S.,
and Akhmedov, A. T.
(1999)
J. Biol. Chem.
274,
34337-34442
46.
Powers, C. A.,
Mathur, M.,
Raaka, B. M.,
Ron, D.,
and Samuels, H. H.
(1998)
Mol. Endocrinol.
12,
4-18
47.
Nehls, P.,
Keck, T.,
Greferath, R.,
Spiess, E.,
Glaser, T.,
Rothbarth, K.,
Stammer, H.,
and Werner, D.
(1998)
Nucleic Acids Res.
26,
1160-1166
48.
Zamir, I.,
Dawson, J.,
Lavinsky, R. M.,
Glass, C. K.,
Rosenfeld, M. G.,
and Lazar, M. A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
14400-14405
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. V. Heemers and D. J. Tindall Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex Endocr. Rev., December 1, 2007; 28(7): 778 - 808. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kosoy, T. M. Calonge, E. A. Outwin, and M. J. O'Connell Fission Yeast Rnf4 Homologs Are Required for DNA Repair J. Biol. Chem., July 13, 2007; 282(28): 20388 - 20394. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Wu, W.-C. Kuo, W.-L. Hwu, K.-Y. Hwa, R. Mantovani, and Y.-M. Lee RNF4 Is a Coactivator for Nuclear Factor Y on GTP Cyclohydrolase I Proximal Promoter Mol. Pharmacol., November 1, 2004; 66(5): 1317 - 1324. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Curtin, H. A. Ferris, M. Hakli, M. Gibson, O. A. Janne, J. J. Palvimo, and M. A. Shupnik Small Nuclear RING Finger Protein Stimulates the Rat Luteinizing Hormone-{beta} Promoter by Interacting with Sp1 and Steroidogenic Factor-1 and Protects from Androgen Suppression Mol. Endocrinol., May 1, 2004; 18(5): 1263 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pero, F. Lembo, E. A. Palmieri, C. Vitiello, M. Fedele, A. Fusco, C. B. Bruni, and L. Chiariotti PATZ Attenuates the RNF4-mediated Enhancement of Androgen Receptor-dependent Transcription J. Biol. Chem., January 25, 2002; 277(5): 3280 - 3285. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Saville, H. Poukka, M. Wormke, O. A. Janne, J. J. Palvimo, M. Stoner, I. Samudio, and S. Safe Cooperative Coactivation of Estrogen Receptor alpha in ZR-75 Human Breast Cancer Cells by SNURF and TATA-binding Protein J. Biol. Chem., January 18, 2002; 277(4): 2485 - 2497. [Abstract] [Full Text] [PDF] |
||||
| ||||||